复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
复星医药(600196) 利润表
单位:万元
报表日期2021-03-312020-12-312020-09-302020-06-302020-03-31
一、营业总收入805,612.023,030,698.132,210,274.431,402,816.46588,050.72
营业收入805,612.023,030,698.132,210,274.431,402,816.46588,050.72
二、营业总成本746,284.312,859,471.852,056,270.541,302,505.20557,683.25
营业成本382,421.351,343,117.79975,451.71621,587.17263,865.18
营业税金及附加5,614.5721,733.8615,883.129,715.304,344.51
销售费用213,950.98846,394.32628,208.19393,106.70168,104.84
管理费用67,366.27296,249.17200,247.41128,807.1558,645.64
财务费用12,847.3472,427.3148,710.0628,846.3313,459.70
研发费用64,083.80279,549.41187,770.05120,442.5549,263.39
资产减值损失----------
公允价值变动收益5,369.8857,865.70342.442,339.35-22,591.95
投资收益47,377.56228,398.09167,290.76117,571.4364,889.40
其中:对联营企业和合营企业的投资收益25,858.73158,033.48108,583.5265,240.6420,098.07
汇兑收益----------
三、营业利润115,946.41472,114.53338,997.05232,203.1978,958.09
加:营业外收入383.692,308.421,255.88917.19354.53
减:营业外支出1,812.656,638.514,226.752,951.542,376.54
其中:非流动资产处置损失----------
四、利润总额114,517.45467,784.44336,026.19230,168.8576,936.07
减:所得税费用16,651.7973,786.4661,037.3139,208.1012,087.13
五、净利润97,865.66393,997.98274,988.88190,960.7464,848.94
归属于母公司所有者的净利润84,718.56366,281.29247,898.06171,471.0257,719.80
少数股东损益13,147.1027,716.6827,090.8219,489.737,129.14
六、每股收益
基本每股收益(元/股)0.33001.43000.97000.67000.2300
稀释每股收益(元/股)0.33001.43000.97000.67000.2300
七、其他综合收益7,242.52-58,984.46-10,019.10-15,496.67-21,246.82
八、综合收益总额105,108.18335,013.52264,969.78175,464.0743,602.12
归属于母公司所有者的综合收益总额92,563.80311,899.95244,950.35166,054.7344,750.63
归属于少数股东的综合收益总额12,544.3823,113.5720,019.439,409.34-1,148.51
下载全部历史数据到excel中 返回页顶